DSIP

Delta Sleep-Inducing Peptide — a neuropeptide naturally found in the brain that modulates sleep architecture and the stress response. DSIP supports the body's natural cues for delta-wave (deep) sleep, the phase most associated with overnight repair, hormone release, and memory consolidation.

Subcutaneous injection, typically in the evening, per a physician-determined protocol. Typical cycles run 4–8 weeks. Your provider will walk you through dosing, timing, and injection technique.

Individuals whose sleep quality — not just duration — has shifted: sleeping 7–8 hours but waking unrested, struggling to reach deep sleep, or managing stress-disrupted sleep patterns. Also relevant for frequent travelers, shift workers, and adults whose sleep has declined with age.

May not be appropriate for individuals who are pregnant or nursing, have active neurological or psychiatric conditions, or have certain chronic medical conditions. Your prescribing clinician will review your full medical history before recommending a protocol.

Generally well tolerated, with possible injection-site reactions, mild morning drowsiness during the initial cycle, or vivid dreaming. Rare but more serious risks include allergic reactions. Your prescribing clinician will review benefits, risks, and monitoring requirements before starting.

No. DSIP supports your body's natural sleep architecture, but it works best alongside consistent sleep hygiene — regular sleep and wake times, reduced evening screen exposure, and a calm pre-bed environment.